Published in
Elsevier, Clinical Lymphoma, Myeloma and Leukemia, 11(21), p. e886-e894, 2021
DOI: 10.1016/j.clml.2021.06.021
Links
Tools
Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma
Journal article published in 2021 by
Matthew J. Matasar,
Martin Dreyling,
Sirpa Leppä 
,
Armando Santoro ,
Michael Pedersen,
Viktoriya Buvaylo,
Monique Fletcher,
Barrett H. Childs,
Pier Luigi Zinzani
,
Armando Santoro ,
Michael Pedersen,
Viktoriya Buvaylo,
Monique Fletcher,
Barrett H. Childs,
Pier Luigi Zinzani
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 